Prior Authorization: A Patient's Guide to Getting Approvals

Prior authorization — the process by which a health insurer reviews and approves a treatment, medication, or procedure before a patient receives it — sits at the intersection of clinical care and administrative gatekeeping. This page explains what prior authorization is, how the review process works step by step, which medical situations most commonly require it, and where the approval boundaries actually fall. For anyone navigating the broader landscape of patient services, prior authorization is one of the most consequential processes to understand.

Definition and scope

Prior authorization (PA), also called "preauthorization" or "precertification," is a utilization management tool used by health insurance plans to determine whether a proposed service is medically necessary and covered under a patient's specific policy before that service is rendered. It is not a guarantee of payment — a point that trips up patients and providers alike — but an advance review that significantly increases the likelihood of coverage.

The scope of prior authorization in the United States is substantial. The American Medical Association's 2023 survey of physicians found that 94% of doctors reported that PA causes delays in patient care (AMA, 2023 Prior Authorization Survey). Insurers operating under Medicare Advantage plans, commercial plans, and Medicaid managed care programs all deploy PA requirements, though the specific triggers vary widely by plan design.

Federal regulations set a floor for some timelines. Under rules finalized by the Centers for Medicare & Medicaid Services, Medicare Advantage plans must respond to urgent PA requests within 72 hours and standard requests within 7 calendar days (CMS, Medicare Advantage Prior Authorization Rule, 42 CFR §422.138).

How it works

The prior authorization process follows a predictable sequence, though the experience can feel anything but predictable when a patient is waiting.

Provider initiates the request. A physician, specialist, or hospital submits a PA request to the patient's insurer — typically by fax, phone, or through a payer portal — along with clinical documentation supporting the medical necessity of the requested service.
Insurer assigns a reviewer. The plan routes the request to a clinical reviewer, often a registered nurse or pharmacist for initial review. Physician reviewers handle cases requiring clinical judgment calls.
Medical necessity determination. The reviewer compares the submitted documentation against the plan's coverage criteria, which are typically based on InterQual or Milliman Care Guidelines — proprietary clinical decision-support tools used across the industry.
Approval, denial, or peer-to-peer request. The insurer issues an approval, a denial, or requests a peer-to-peer consultation — a direct conversation between the ordering physician and the plan's medical reviewer. Peer-to-peer calls reverse a meaningful share of initial denials.
Patient and provider notification. Both parties receive the determination in writing, with denied requests required to include the specific clinical rationale and appeal rights under state and federal law.

The contrast between urgent and standard timelines matters enormously in practice. A patient waiting on approval for elective joint replacement surgery operates on a different timeline than one awaiting authorization for a medically urgent chemotherapy regimen — and plans are legally required to treat those situations differently.

Common scenarios

Prior authorization requirements cluster around categories that insurers flag as high-cost, high-variability, or potentially overutilized.

Specialty medications top the list. Brand-name biologics used in rheumatoid arthritis, psoriasis, Crohn's disease, and oncology almost universally require PA — and many plans require documented failure of a less expensive drug first, a practice called "step therapy."

Imaging studies — particularly MRI, CT, and PET scans — routinely require preauthorization under commercial plans. A primary care physician ordering a lumbar MRI for back pain will typically trigger a PA review.

Surgical procedures including spinal surgery, bariatric surgery, and some cardiac interventions require advance approval. Insurers often require documented conservative treatment trials before approving surgical options.

Behavioral health services present a distinct pattern. Inpatient psychiatric admissions and intensive outpatient programs frequently require authorization, and plans may conduct concurrent reviews — reassessing continued medical necessity every few days during an inpatient stay. Patients navigating behavioral health patient services often encounter PA requirements at multiple points in a single episode of care.

Durable medical equipment (DME) such as CPAP machines, power wheelchairs, and insulin pumps typically require supporting documentation of diagnosis, failed alternatives, and functional limitations before a plan will approve coverage.

Decision boundaries

Understanding where approvals end and denials begin requires grasping the logic insurers use — and where that logic has legal limits.

Insurers must base PA decisions on the plan's coverage criteria, which must themselves align with accepted clinical standards. Plans cannot deny coverage solely on cost grounds. Under the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA, 29 U.S.C. §1185a), insurers are prohibited from applying more restrictive PA requirements to mental health and substance use disorder benefits than to comparable medical and surgical benefits — though enforcement remains uneven.

State laws add additional boundaries. As of 2024, 17 states have enacted gold-carding laws that exempt physicians with high PA approval rates from having to obtain authorization for certain services (KFF, State Prior Authorization Laws, 2024). California's SB 1120 and Texas's HB 3459 are among the most cited examples of this legislative trend.

When a PA request is denied, patients retain the right to an internal appeal followed by an external independent review — a right codified under the Affordable Care Act for plans subject to federal oversight (45 CFR §147.136). External reviewers overturn insurer denials at rates that vary by condition type but are meaningfully higher than zero — making appeal a genuinely worthwhile avenue rather than a procedural formality.

For patients who believe the process has been applied unfairly, the patient grievance and complaint process provides a structured path to challenge coverage decisions at the plan and regulatory level.

References

📜 4 regulatory citations referenced · 🔍 Monitored by ANA Regulatory Watch · View update log